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Abstract
Plasmodium knowlesi has entered the human population of Southeast Asia. Naturally acquired knowlesi malaria is newly
described with relatively little available data, including data on the host response to infection. Therefore pre-treatment
cytokine and chemokine profiles were determined for 94 P. knowlesi, and for comparison, 20, P. vivax and 22 P. falciparum,
patients recruited in Malaysian Borneo. Nine, five and one patient with P. knowlesi, P. falciparum and P. vivax respectively
had complicated malaria as defined by World Health Organisation. Patients with uncomplicated P. knowlesi had lower levels
of the pro-inflammatory cytokines IL-8 and TNFa than those with complicated disease (both p,0.05, Dunn’s post test, DPT).
The anti-inflammatory cytokines IL-1ra and IL-10 were detected in all patients in the study. IL-1ra, the most abundant
cytokine measured, correlated with parasitaemia in P. knowlesi (rs=0.47, p= ,0.0001), P. vivax (rs=0.61, p=0.0042) and P.
falciparum (rs=0.57,p=0.0054) malaria. IL-10 correlated with parasitaemia in both P. knowlesi (rs=0.54, p= ,0.0001) and P.
vivax (rs=0.78, p= ,0.0001) infections. There were between group differences in soluble markers of macrophage activation
(MIP-1b and MCP-1). P. knowlesi patients had significantly lower levels of MIP-1b than P. falciparum (DPT, p= ,0.01).
Uncomplicated P. knowlesi patients had significantly lower levels of MCP-1 than uncomplicated P. falciparum patients (DPT,
p= ,0.001). There was no significant difference between complicated and uncomplicated P. knowlesi infections. MCP-1,
MIP-1b, IL-8 and TNFa increased in complicated P. knowlesi but decreased in complicated P. falciparum infections.
Descriptions of human knowlesi malaria provide a comparative means to discover mediators of pathophysiology in severe
P. knowlesi as well as P. falciparum malaria. Crucially, P. knowlesi may be the disease and experimental primate model for
severe malaria.
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Introduction
Plasmodium knowlesi infection is a major cause of malaria in
humans in Malaysian Borneo [1,2]. Approximately 10% of
patients develop severe symptoms when classified by WHO
criteria for disease severity and approximately one percent of cases
have a fatal outcome [3]. Recent post mortem findings from a fatal
P. knowlesi infection show remarkable histological similarities with
P. falciparum, suggesting commonality of some pathophysiological
processes between severe infections caused by different species of
Plasmodium [4]. P. knowlesi and P. falciparum infections can both lead
to hepatorenal dysfunction, acute respiratory distress syndrome
(ARDS), metabolic disturbance and the accumulation of large
numbers of heavily pigmented parasitized red blood cells in brain
and other microvasculatures [4,5,6,7]. ARDS, jaundice renal
dysfunction and anaemia can also occur in complicated P. vivax
malaria [8,9,10,11]. However, despite accumulation of P. knowlesi
infected erythrocytes in brain vessels, coma is not a feature of fatal
knowlesi infection. The severity of anaemia associated with P.
knowlesi may also be less than that seen with P. falciparum and P.
vivax infection although this complication has not been studied
systematically.
In fatal knowlesi malaria, progression from the onset of
symptoms to the development of high parasitiaemia and death
can be swift, and may be as short as 3 days [1,4]. After reviewing
data from cases of severe and fatal knowlesi malaria, we observed
that parasitaemia might be a better marker of disease severity than
for other species of human malaria [3]. Sequestration of mature
stage parasites from peripheral blood circulation in P. falciparum
infections precludes the possibility of determining accurate
estimates of asexual stage parasitaemia by microscopy and
therefore of using parasitaemia as a reliable marker of disease
severity in falciparum malaria [12]. Difficulty in making direct
associations between parasitaemia and pathophysiology in falci-
parum malaria have hampered research on identifying parasite
virulence, particularly in relation to estimating thresholds for the
development of severe disease [13]. Within the context of host
response to acute malaria, quantifiable measures of disease
severity, parasitaemia and soluble mediators of immune response
were measured in clinically and parasitologically well-charac-
terised P. knowlesi, P. falciparum and P. vivax infections. Although
falciparum and vivax patients had mostly imported malaria they
were retained in the study to provide contemporaneous and other
information for comparison. We test the hypothesis that soluble
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presentation, including circulating parasitaemia, in P. knowlesi, P.
vivax and P. falciparum infections. We also comment on the
influence of innate immunity on disease outcome. Our results
provide new insights into the pathophysiology of this emerging
human pathogen, which can be viewed both as a human model of
an animal infection as well as the reverse.
Results
Patients
All patients recruited into the study had PCR confirmed single
species infections and had not received anti-malarial treatment
within the preceding 14 days of admission. Pre-treatment serum
and plasma samples were available for 94 P. knowlesi,2 0P. vivax
and 22 with P. falciparum patients and were included in the study
presented here. Admission clinical and laboratory variables for
these patients are summarised in Table S1 as some of these data
have been published previously [3].
The number of P. falciparum patients recruited in Malaysian
Borneo was small (n=22), so we assessed how representative the
information from this group was for P. falciparum infections by
comparing the data with that available from 304 P. falciparum
patients admitted to St George’s Healthcare NHS Trust. There
were no significant differences between patients from St. George’s
(all available data) and Malaysia for parasitaemia, haemoglobin,
total white cell and platelet counts (Table S2).
Eight (8.5%) patients with P. knowlesi had complicated malaria,
with one (1%) fatal case that was included in the complicated
group for analysis. One patient (5%) with P. vivax malaria had
anaemia and 5 (22.7%) with P. falciparum had complications
defined as severe by WHO criteria (summarised in Table S3).
Parasitological features of infection
The admission parasitaemia differed significantly between
groups (Kruskal-Wallis (K–W), p= ,0.0001) (Figure 1). Para-
sitaemia in the uncomplicated P. knowlesi patient group (median
1,030; IQR 337–3,141 parasites/mL) was lower than parasitae-
mia in uncomplicated falciparum infections (median 23,142;
IQR 8,254–59,367 parasites/mL: Dunn’s post test (DPT) p=
,0.001) as well as those with complicated P. knowlesi (median
21,715; IQR 4,298–148,326 parasites/mL: DPT, p=0.01). P.
knowlesi parasitaemia correlated with many clinical and labora-
tory markers of disease severity as listed in Table S2 (see
Table 1). Interestingly, liver and renal function, white cell
counts and serum lactate all correlated with parasitaemia in
knowlesi malaria (Table 1). The range of parasitaemias in vivax
and falciparum infections was limited compared with P. knowlesi
(Figure 1), nevertheless, P. vivax parasitaemia correlated with
neutrophils and lymphocytes and P. falciparum with lactate and
glucose (Table 1).
Platelet counts significantly differed between groups (K–W, p=
,0.0001). Platelet counts were lower in P. knowlesi infections
(median 59,500; IQR 41,500–100,500 /mL) than in P. vivax
(median 108,800; IQR 68,000–151,000/mL: DPT, p= ,0.01) but
not P. falciparum patients recruited in Sarawak (median 84,500;
IQR 55,500–144,000 /mL: DPT, ns). When platelet counts from
the P. knowlesi patient group in Sarawak were compared with those
of 304 P. falciparum patients in the comparative group from the St
George’s Healthcare NHS Trust (median 108,000; IQR 76,500–
151,000/mL) platelets were significantly lower in P. knowlesi
patients (Mann-Whitney U test, p= ,0.0001), see Table S2.
Platelet counts had an inverse significant correlation with
parasitaemia in P. knowlesi infections (Table 1).
Characteristics of host response to infection
The cytokines IL-1a, IL-4, IL-17 and GM-CSF in all types of
malaria in this study were not detected or were detected in too few
patients to be informative. Table 2 summarises the cytokine and
chemokine profiles by species and disease severity. Significant
Figure 1. Differences in parasitaemia between species. Pk =P.
knowlesi,P v =P. vivax and Pf =P. falciparum. U= patients with
uncomplicated disease and C= patients with complicated. The point
corresponding the P. vivax patient with complicated disease is shaded.
The Kruskal-Wallis test was significant (p= ,0.0001) for between group
differences. Dunn’s post test values are shown when p= ,0.05.
doi:10.1371/journal.pone.0020541.g001
Table 1. Correlations of parasitaemia with clinical and
laboratory variables.
Variable P. knowlesi P. vivax P. falciparum
rs rs rs
Fever Clearance (hrs) 0.35** ns ns
Leucocytes/mL 0.44*** ns ns
Neutrophils/mL 0.52*** 0.53* ns
Lymphocytes/mLn s20.49* ns
Platelets/mL 20.29** ns ns
Serum creatinine (mmol/L) 0.35*** ns ns
Total bilirubin (mmol/L) 0.26* ns ns
Serum lactate (mmol/L) 0.28** ns 0.46*
Serum glucose (g/L) ns ns 0.49*
Immature trophozoites (%) ns 0.55* ns
Clinical and laboratory variables with significant associations with parasitaemia
are shown. Spearman’s rank correlation ‘rs’ value is given; * p,0.05, ** p,0.01
and *** p,0.001; ‘–’ denotes inverse associations and ns = no significant
correlation. Variables that are not shown displayed no correlation with
parasitaemia in all three species of infection. All variables and total number of
patients in each group per variable are listed in Table S1.
doi:10.1371/journal.pone.0020541.t001
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infecting parasite species are summarised (Figure 2, and Table
S4). Parasitaemia was associated with a different cytokine profile in
each infecting species of Plasmodium. P. knowlesi and vivax malaria
patients produced similar associations except that MCP-1 weakly
correlated with parasitaemia in P. knowlesi (rs 0.22, p=0.0318) but
strongly in P. vivax infections (rs 0.72, p=0.0003). By contrast,
parasitaemia in falciparum malaria was a poor correlate of
immune mediators and, apart from IL-1ra, was different from that
observed for knowlesi and vivax malaria patients, including an
association with IL-1b that was not seen in infections with the
other two species (Figure 2).
Figure 2. Comparison of significant (p= ,0.05)correlations between P. falciparum, P. knowlesi and P. vivax parasitaemia and immune
mediators. Columns show cytokines and chemokines divided by function or cell source; a) pro-inflammatory, b) anti-inflammatory, c) macrophage/
dendritic cell derived and d) IL-2 and VEGF growth factors. The arrow shows level of significance of each association (Spearman’s rank correlation
test). * VEGF is inversely associated with P. knowlesi parasitaemia.
doi:10.1371/journal.pone.0020541.g002
Table 2. Cytokine and chemokine results summarised by patient group.
Soluble immune
mediators (pg/mL) P. knowlesi P. vivax P. falciparum
Uncomplicated
(n=85)
Complicated
(n=9)
all*
(n=20)
Uncomplicated
(n=17)
Complicated
(n=5)
IL-1b 1.37(1.37–1.37) 1.37(1.37–9.04) 1.37(1.37–1.37) 1.37(1.37–4.07) 1.37(1.37–16.65
Il-1ra 6759.44 (4627.37–
10250.67)
16400 (9637.98–20311) 17775.35(6064.97–
23081.75)
12254.4(5235.04–
19072.84)
18301.61(7151.19–
21581.81)
IL-2 1.44(1.44–1.44) 2.64(1.44–15.17) 4.12(1.44–16.41) 3.55(1.44–8.86) 6.49(1.44–10.78)
IL-6 14.76(9.43–37.47) 81.25(23.63–786.6) 32.53(5.53–176.18) 35.07(17.53–80.6) 47.2(12.61–889.48)
IL-8 17.67(11.6–31.0) 38.77(31.75–142.12) 24.97(8.76–82.4) 51.83(19.5–87.79) 29.62(5.13–443.15)
IL-10 164.67(68.05–321.65) 195.31(117.94–3376.61) 738.21(77.26–2727.44) 210.62(98.03–694.84) 241.76(87.37–2697.95)
TNFa 13.84(6.07–24.37) [79] 58.51(28.55–90.06) 24.66(9.79–58.67) 37.23(18.75–46.45) 24(5.23–133.46)
IFNc** ,2.27(,2.27–4.21) [82] ,2.27(,2.27–,2.27) ,2.27(,2.27–,2.27) ,2.27(,2.27–,2.27) ,2.27(,2.27–24.4)
MIP-1b (CCL4) 105.48(70.46–148.65) 183.51(86.27–426.4) 144.55(73.58–1041.34) 410.16(155.81- 632.76) 117.24(81.78–948.61)
MCP-1 (CCL2) 212.07(131.01–333.17) 291.17(199.12–518.21) 378.57(136.51–8400) 694.34(298.78–1704.27) 208.65(79.14–6434.0)
VEGF 70.21(39.34–109.24) 30.7(3.64–99.02) 83.87(53.66–125.43) 89.05(69.35–133.96) 134.32(34.98–195.25)
*One vivax patient had complicated disease.
**IFNc levels too low to be detected were entered as ,2.27 pg/ml. The value 2.27 pg/mL is half of the detection limit of the assay.
Results are summarised as median (Interquartile range). Number in square brackets indicates the number of patients when ‘n’ is different from the total.
doi:10.1371/journal.pone.0020541.t002
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IL-1ra was the most abundant cytokine measured and was
associated with complications in P. knowlesi patients (rs0.34, p=
0.0007) but not in the P. falciparum group (Table 3). IL-1ra in all
three species was a correlate of cytokines, including IFNc, and
chemokines in P. knowlesi (Table 3). There were significant between
group differences for IL-1ra (K–W, p=0.001), but not IL-10. IL-
10 was not associated with complications but was associated with
neutrophil and lymphocyte counts in P. knowlesi and P. vivax
patients and with other circulating immune mediators in all three
species (Table 3). IL-1ra and IL-10 were detected in all patients
recruited into the study (Figure 3).
Pro-inflammatory cytokines IL-1b, IL-6, IL-8, TNFa and
IFNc
Consistent with high levels ofIL-1ra,IL-1b wasdetected inonly6
(6.3%), 3 (15%) and 8 (36%) of P. knowlesi, P. vivax and P. falciparum
infections respectively. There were significant between group
differences for IL-6 (K–W, p=0.0019) although post-tests were
not significant (DPT, ns). IL-6 was undetectable in 17 (18%), 2
(10%) and 1 (4.5%) P. knowlesi, P. vivax and P. falciparum patients
respectively. The were significant between group differences for IL-
8 (K–W, p=0.0007) IL-8 was significantly higher in P. knowlesi
complicated cases (median 38.77; IQR 31.75–142.1 pg/mL)
compared with uncomplicated disease (median 17.67; IQR
11.69–31.75 pg/mL: DPT, p=,0.05). IL-8 was not detected in
five (5%) P. knowlesi and one (5%) P. vivax patient. There were
significant between group differences for TNFa (K–W,
p=,0.0001). TNFa was significantly lower in uncomplicated P.
knowlesi patients (median 13.84; IQR 6.070–24.37 pg/mL) com-
pared with uncomplicated P. falciparum patients (median 37.23;
IQR18.75–46.45 pg/mL: DPT, p= ,0.01) and complicated P.
knowlesi patients (median 58.51; IQR 28.55–90.06 pg/mL: DPT,
p=,0.001). IFNc was not detected in 62 (68%) of P. knowlesi,1 9
(95%) P. vivax and 19 (86%) P. falciparum patients. Ten samples had
relatively increased IFNc levels (.10 pg/mL). All but three of these
wereinthe P. knowlesi uncomplicated group,with oneandtwointhe
P. knowlesi and P. falciparum complicated groups respectively.
Growth factors (IL-2 and VEGF)
There were significant between group differences for IL-2 (K–
W, p= ,0.0001). IL-2 was detected in 17%, 75% and 59% of P.
knowlesi, P. vivax and P. falciparum patients respectively. Conse-
quently IL-2 levels were significantly lower in P. knowlesi (median
1.440; IQR1.440–1.440 pg/mL) compared with P. vivax (median
4.115; IQR 1.585–14.95 pg/mL: DPT, p= ,0.001) and P.
falciparum patients (median 3.775; IQR 1.440–8.470 pg/mL: DPT,
p=0.01). It should be noted that there were between species
differences in lymphocyte counts (K–W, p=0.0022). P. knowlesi
patients had higher lymphocytes counts (median 1,500; IQR
1050–1900 mL/mL, DPT, ns)) than P. vivax (median 900; IQR
600–1,575/mL, DPT, ns) and P. falciparum patients (median 1000;
IQR 700–1400/mL, DPT, ns). There were no significant between
group differences for VEGF.
Table 3. Associations between variables measured, IL-1ra and IL-10.
Variables P. knowlesi (n=94) P. vivax (n=20) P. falciparum (n=22)
IL-1ra IL-10 IL-1ra IL-10 IL-1ra IL-10
rs rs rs rs rs rs
Complications 0.34*** ns - - ns ns
Neutrophils /mL 0.45*** 0.42*** Ns 0.62** ns ns
Lymphocytes /mLn s 20.32** 20.71*** 20.68** ns ns
Platelets/mLn s n s 20.71*** ns ns ns
Creatinine mmol/L 0.24* ns Ns ns ns ns
Total bilirubin mmol/L 0.31** ns 0.47* ns ns ns
AST U/L 0.29** ns Ns ns ns ns
Glucose g/L 0.24* ns Ns ns 0.45* ns
Parasites/mL 0.47*** 0.54*** 0.61** 0.78*** 0.57** ns
% Immature Trophozoites 0.27** 0.41*** 0.49* 0.53* 22
IL-1b pg/mL 0.26* 0.26* Ns 0.47* 0.73*** 0.61**
IL-1ra pg/mL 2 0.60*** 2 0.86*** 2 0.83***
IL-2 pg/mL 0.52*** 0.41*** 0.76*** 0.83*** 0.90*** 0.81***
IL-6 pg/mL 0.59*** 0.61*** 0.76*** 0.92*** 0.75*** 0.82***
IL-8 pg/mL 0.53*** 0.39*** 0.75*** 0.85*** 0.69*** 0.67***
IL-10 pg/mL 0.60*** 2 0.86*** 2 0.83*** 2
TNFa pg/mL 0.56*** 0.29** 0.82*** 0.90*** 0.59** 0.72***
IFNc pg/mL 0.36*** ns Ns ns ns ns
MIP-1b pg/mL 0.33** 0.41*** 0.71*** 0.78*** 0.68*** 0.67***
MCP-1 pg/mL 0.38*** 0.53*** 0.80*** 0.86*** 0.49* 0.68***
VEGF pg/mL ns 20.23* Ns ns ns ns
Spearman’s rank correlation ‘rs’ value is given; *p,0.05, **p,0.01 and ***p,0.001, ‘–’ denotes inverse associations and ns = no significant correlation. Variables that are
not shown displayed no correlation with Il-1ra or IL-10 in all three species of infection.
doi:10.1371/journal.pone.0020541.t003
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There weresignificantbetween groupdifferencesforMIP-1b and
MCP-1 levels (K–W, p= ,0.0001 for both). P. knowlesi patients had
significantly lower levels of MIP-1b (median 110.0; IQR 73.48–
155.9 pg/mL) than P. falciparum (median 382.3; IQR 129.5–
708.0 pg/mL: DPT, p=,0.01) but not P. vivax patients (median
144.6 ; IQRI 80.30–838.4 pg/mL). There was no significant
difference between the P. vivax and P. falciparum groups. MIP-1b was
a strong correlate of TNFa in P. vivax (rs, 0.66) and P. falciparum
(rs, 0.85) with a weak correlation in P. knowlesi patients (rs, 0.22)
(Table 4). Patients with P. knowlesi malaria had significantly lower
MCP-1 levels (median 215.0; IQR 131.2–341.2 pg/mL) compared
with those infected with P. falciparum (median 614.3; IQR 226.3–
1680.0 pg/mL:DPT,p= ,0.01).Therewasnosignificantincrease
in MCP-1 in complicated P. knowlesi patients. MCP-1 correlated
with other cytokines measured including TNF a and haemoglobin
in P. falciparum (Table 4). Four vivax and two falciparum patients
had MCP-1 levels greater than the detection level of the assay.
Figure 3. Anti-inflammatory mediators IL-1ra and IL-10 were detected in all patients in the study. Pk =P. knowlesi,P v=P. vivax and Pf
=P. falciparum. U= patients with uncomplicated disease and C= patients with complicated disease. The points corresponding to the P. vivax patient
with complicated disease are shaded. Horizontal lines appear at the median values. The Kruskal-Wallis test was significant (p=0.0001) for IL-1ra but
not IL-10. Dunn’s post test values are shown when p= ,0.05.
doi:10.1371/journal.pone.0020541.g003
Table 4. Correlates of macrophage and monocyte activation.
Variable P. knowlesi (n=94) P. vivax (n=20) P. falciparum (n=24)
MIP-1b (CCL4) rs MCP-1 (CCL2) rs MIP-1b (CCL4) rs MCP-1 (CCL2) rs MIP-1b (CCL4) rs MCP-1 (CCL2) rs
Haemoglobin g/dL ns ns ns Ns ns 0.56**
Lymphocytes/mL 20.24* 20.44*** 20.64** 20.70*** ns 20.51*
Se Creatinine mmol/L ns ns ns Ns 0.44* ns
Total parasitaemia/mL 0.30** 0.22* 0.61** 0.72*** ns ns
% Immature Trophozoites ns 0.34*** 0.69*** 0.54* 22
History of fever (days) ns ns 20.54* 20.54* ns ns
Fever clearance (days) ns ns ns Ns ns 0.45*
Axillary Temp
oC ns ns ns 0.62** ns ns
IL-1b pg/mL ns ns ns Ns 0.71*** ns
IL-1ra pg/mL ns 0.38*** ns 0.80*** 0.68*** ns
IL-2 pg/mL ns 0.45*** 0.68*** 0.74*** 0.69*** 0.55**
IL-6 pg/mL 0.40*** 0.42*** 0.74*** 0.88*** 0.82*** 0.71***
IL-8 pg/mL 0.38*** 0.36*** 0.76*** 0.85*** 0.72*** 0.76***
IL-10 pg/mL 0.41*** 0.53*** 0.78*** 0.86*** 0.67*** 0.68***
TNFa pg/mL 0.22* 0.32** 0.66** 0.82*** 0.85*** 0.64**
MCP-1 0.33** 2 0.85*** 2 0.73*** 2
Spearman’s rank correlation ‘rs’ value is given; *p,0.05, ** p,0.01 and ***p,0.001, ‘–’ denotes inverse associations and ns = no significant correlation. Variables that
are not shown displayed no correlation with MIP-1b or MCP-1 in all three species of infection.
doi:10.1371/journal.pone.0020541.t004
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Changes in immune mediators between patients with uncom-
plicated and complicated disease in P. knowlesi and P. falciparum
infections are summarised in Figure 4. The pro-inflammatory
mediators TNFa and IL-8 increased in P. knowlesi patients but
decreased in P. falciparum complicated infections (Figure 4,
columns ‘a’ in left and right panels). The anti-inflammatory
cytokines were comparable between the two infections (Figure 4
columns ‘b’ in both panels). MIP-1b and MCP-1 decreased in
patients with complicated P. falciparum but increased in those with
complicated P. knowlesi (Figure 4, columns ‘c’ in both panels).
VEGF decreased in P. knowlesi but increased in P. falciparum
patients (Figure 4, columns ‘d’ in both panels).
Discussion
We have noted previously that thrombocytopenia, mild to
moderate hyponatremia, deranged liver function jaundice, renal
impairment and hypotension are complications of human knowlesi
malaria [1,3,4]. We now demonstrate that measures of disease
severity at presentation are more often associated with parasitae-
mia in P. knowlesi than in P. vivax and P. falciparum infections.
Soluble immune mediators associate with parasitaemia in P.
knowlesi and P. vivax but less so in P. falciparum malaria. The
falciparum and vivax patient groups were equally small and the
lack of association, particularly in soluble immune mediators,
between parasitaemia in patients with P. falciparum is possibly a
reflection of sequestration of all but immature trophozoite infected
cells and in consequence the unreliability of estimating parasitae-
mia from peripheral blood samples [12].
Soluble immune mediators measured pre-treatment were
used as surrogate markers of immune activity in our patients. In
this study host response profiles of symptomatic patients, in all
three species of Plasmodium, were those of anti-inflammatory
regulation by IL-1ra and IL-10. IL-1ra regulates the pro-
inflammatory biological properties of IL-1 and was the most
abundant circulating cytokine. IL-1ra concentrations also
correlate with parasitaemia in all three species. Interestingly
IL-1ra and Il-10 serum concentrations are positively associated
with percent immature trophozoites in P. knowlesi and P. vivax
infections indicating host response to schizont rupture events. It
is possible that anti-inflammatory cytokines are released to
modulate the expected immune surge during schizont rupture
and reinvasion.
Figure 4. Diagrammatic representation of percentage change in median values of immune mediators between uncomplicated and
complicated disease in P. falciparum and P. knowlesi infections as reported (Table 2). Columns show cytokines and chemokines grouped by
function or cell source; a) pro-inflammatory, b) anti-inflammatory, c) macrophage/dendritic cell derived and d) IL-2 and VEGF growth factors. The
arrows indicate percent and direction of change.
doi:10.1371/journal.pone.0020541.g004
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stimuli including normal homeostasis and IL-10 has been variously
implicated in malaria pathophysiology [14,15,16,17]. IL-10 was
detected in all patient groups in our study. IL-10 was positively
associated with parasitaemia in P. knowlesi and P. vivax infections.
In both falciparum and knowlesi patients IL-10 levels, while
elevated, were not associated with markers of disease severity. Our
results contrast with findings from Brazil where parasitaemia was
significantly higher in severe compared with mild vivax infections
and IL-10 levels significantly lower [18].
Different macrophage subsets in patients, including those
secreting IL-10, have been shown to alter malaria pathology [19].
In our study there were differences in both the manifestations of
disease severity in P. knowlesi and P. falciparum patients and the
markers of macrophage activation MIP-1b (CCL-4) and MCP-1
(CCL2). Both chemokines were lower in P. knowlesi compared with
P. falciparum patients. In falciparum patients MIP1b but not MCP-1
was strongly associated with IL-1ra while the opposite was true for
vivax and knowlesi patients. Subtle differences in macrophage
activity may account for some of the differences in manifestations of
diseaseseveritybetweenpatientsinfected withdifferentPlasmodium
species,forexamplehypotensionand renalimpairmentinP.knowlesi
and severe anaemia in P. falciparum infections. MCP-1 attracts
monocytes, irrespective of subset, therefore MCP-1 (CCL2) activity
is not necessarily characterised by a heightened pro-inflammatory
IFNc response [17,19]. In support of an anti-inflammatory
macrophage sub-set activity in our patients, circulating IFNc was
not predominant in P. knowlesi, P. falciparum or P. vivax malaria in this
study. MIP1b (CCL-4) is produced by macrophages in response to
foreign particle stimulus and can induce IL-1, IL-8 and TNFa.
MIP1b was strongly correlated with these cytokines in P. falciparum
patients in our study but not with IL-1 in P. vivax and P. knowlesi and
weaker association with TNFa in P. knowlesi patients. Interestingly,
neitherchemokinewas associated with markers ofdiseaseseverityin
P. knowlesi but MCP-1 (CCL2) was strongly associated with
haemoglobin in P. falciparum. Severe anaemia was a feature of P.
falciparum but not P. knowlesi patients. The association between
MCP-1 (CCL2) and haemoglobin, one of the few clinical
associations found in falciparum patients in this study, adds support
to the idea that the relative weight of macrophage subset activation
may influence malaria pathophysiology between patients and
between infecting Plasmodium species.
Neutrophil counts strongly correlate with P. knowlesi parasitae-
mia and neutrophils were also increased in our P. vivax and P.
falciparum patient groups. Also P. knowlesi patients were more
thrombocytopenic than those with P. vivax and P. falciparum
malaria. Here we make a case for the interplay of innate immune
mediators, particularly platelets and neutrophils, in controlling
pre-treatment parasitaemia.
In the non-immune the host-parasite interface early in infection
would be expected to involve pattern recognition motifs on
merozoite surfaces, infected erythrocyte surfaces and other
substances released during asexual life-cycling [20]. In acute
malaria, these interactions are initiated and contained within the
red blood cell circulatory compartment with additional parasite
clearance activity in the spleen and other well protected endothelial
surfaces including those serving the liver, lung, brain and bone
marrow. Monocytes, macrophages, endothelial cells, neutrophils
andplatelets areall equipped with pattern recognitionreceptors,the
Toll-like receptors (TLR) [21]. Of these, platelets and neutrophils
are the most numerous, mobile and likely to encounter merozoites
and parasite-altered erythrocytes early in infection.
Thrombocytopenia is often studied in bacterial sepsis and is
associated with features of disseminated intravascular coagulation
and a poor prognosis [22]. These features are not consistent with
thrombocytopenia in malaria, especially in acute uncomplicated
knowlesi malaria where thrombocytopenia is a characteristic. An
anti-parasitic associated, rather than coagulopathy - associated,
thrombocytopenia would better explain thrombocytopenia in
uncomplicated malaria together with the rapid recovery of
circulating platelets following treatment [3]. In support of this,
platelets with TLR 2,4 and 9 [22] can actively kill P. falciparum (in
vitro) and P. chabaudi (in vivo) [23]. During the killing process
platelets bind to infected red blood cells and we propose that
thrombocytopenia in uncomplicated P. knowlesi infection reflects a
killing process beneficial to the host rather than deleterious platelet
depletion [24]. Further investigation of the contribution of
platelets in controlling parasitaemia and the events leading to a
breakdown of this type of control may help to inform the rational
development of intervention methods in malaria.
Platelet activation provides the stimulus for leucocytes, includ-
ing neutrophils, to migrate out of the capillary beds to sites of
infection again not particularly applicable in intravascular
Plasmodium infections. Similarly a phagocytic function for activated
neutrophils, and associated host tissue damage through the
respiratory burst, may be expected to produce more harm than
good within the intravascular compartment [25]. In our study,
neutrophils were strongly associated with P. knowlesi parasitaemia
yet there is a lack of evidence for host endothelial cell damage in
human cases of knowlesi malaria, even at post mortem [4].
The strong association between knowlesi parasitaemia and
neutrophils may be explained by considering the pattern of
circulating cytokines. We observed a strong correlation between
neutrophils and the anti-inflammatory cytokines IL-1ra and IL-10
with less evidence for the expected IFN c and TNF a pro-
inflammatory response. Rather, an IL-10 driven response, possibly
with a monocyte origin. Even so it remained difficult to reconcile
an anti-inflammatory, rather than the characteristic pro-inflam-
matory, role for neutrophils in malaria, or to understand the
associated strong IL-1ra signal in our patients. Recently Bazzoni
et al, [26] presented an eloquent anti-inflammatory pathway for
neutrophil activation based on the inter-relationship between
neutrophils, IL-10 and IL-1ra. The IL-10 receptor on neutrophils,
IL-10R2, is constitutively expressed but is not responsive to IL-10
without the co-expression of IL-10R1. IL-10R1 co-expression
requires up-regulation. Bazzoni et al., use the example of
lipopolysaccharide (LPS) binding to TLR-4 for stimulating IL-
10R1co-expression. In the presence of both receptors IL-10
induces neutrophils to synthesise the anti-inflammatory IL-1ra
cytokine [26]. IL-1ra blocks the potent inflammatory IL-1b
response which, if unregulated in infection, would result in host
tissue damage [27,28]. An analogous TLR mediated anti-
inflammatory neutrophil response during the asexual Plasmodium
life cycle would prevent rather than augment an overwhelming
pro-inflammatory response in the vulnerable circulatory compart-
ment. Anti-inflammatory neutrophil function, regulated by IL-10,
would help explain the up-regulation of IL-1ra in our patients and
limitation of disease severity, not only in uncomplicated P. knowlesi,
but also in uncomplicated P. falciparum and P. vivax malaria.
In addition to contributing to understanding human knowlesi
malaria, the human disease, we have demonstrated important
similarities and differences between the three virulent agents of
malaria in humans. Our study was limited by small numbers of
comparator falciparum and vivax patients which may under
power some of the between group statistical analyses and by single
time point sampling. Furthermore, not all possible immune
mediators were measured. However, we provide unequivocal
evidence for an association between parasitaemia, markers of
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hypothesise that platelets and neutrophils are both anti-parasitic
and anti-inflammatory in acute uncomplicated P. knowlesi, P. vivax
and P. falciparum infections. We also add some support to the idea
that activated monocyte and macrophage subsets direct organ-
specific immuno-pathology and may influence manifestations of
severe malaria between infected individuals and infecting
Plasmodium species. We propose that P. knowlesi be both the disease
and the experimental primate model to discover how best to
properly examine and understand these processes with a view to
improving the lives of those most vulnerable to malaria.
Materials and Methods
Patient consent and ethics
Informed written consent was obtained from all patients entered
into these studies that were approved by the Malaysian Ministry of
Health’s Medical Research and Ethics Committee.
Patient recruitment
Adult patients presenting in Kapit district, Malaysian Borneo
with fever and suspected of having malaria were recruited into this
study between July 2006 and February 2009 and subsequently
confirmed by PCR to carry single species Plasmodium infections [3].
Patients with multiple species infections, other co-morbidities or
those who were PCR negative, were excluded retrospectively from
further study. Patients in this study were reported previously in
studies describing clinical features of P. knowlesi infection and
response to therapy [3,29]. Only patients with stored pre-
treatment serum or plasma samples were included in the study
presented here. As described, patients were classified as being
severe based on WHO criteria for severe falciparum malaria in
non-immune individuals [3,30], with the following exception: For
the study presented here we did not consider hyperparasitaemia
(.100,000 parasites/mL) [3] in the absence of other clinical or
laboratory evidence of severe disease as sufficient to classify
patients as having complicated disease.
Falciparum and vivax patients recruited in Malaysian Borneo
were relatively small, demographically different and with a history
of prior exposure to malaria and may not have been comparable
to the mostly untraveled P. knowlesi group [3]. For this reason,
archival haematology and parasitology results from 304 P.
falciparum cases admitted to St George’s Healthcare Trust between
1993 and 1999 were compiled for validation purposes. Some data
conversion was required. Percentage parasitaemias were converted
to parasites /mL by assuming there were 4.5610
6 RBC/mL blood.
Parasitaemias recorded as ,0.01% and ,0.0001% were adjusted
450 and 45 parasites /mL respectively.
Cytokine analysis
Pre-treatment serum was collected and transported in liquid
nitrogen or on dry ice and stored at 240uC or colder. In four
patients, cytokine analysis was carried out on plasma as serum was
unavailable. Comparisons of cytokines in other patients’ plasma
and serum confirmed that only VEGF levels were ,18% lower in
plasma than in serum. This was therefore the only correction
factor applied to the four sets of results from plasma.
Measurement of human cytokine and chemokine levels
FluorokineH MAP MultiAnalyte profiling ELISA for LUMI-
NEX Technology (R&D Systems, Inc.) with Bio-Rad Bio-Plex
System (Bio-Rad Laboratories Inc.) output were used according to
manufacturer’s instructions. The following cytokines and chemo-
kines were measured: IL-1 a, IL-1 b, IL-1ra, IL -2, IL- 4, IL-6, IL-
8, IL-10, IL-17, GM-CSF, TNF a, Interferon c, CCL4 (MIP–b),
CCL2 (MCP-1) and VEGF. Human Fluorokine MAP Multiplex
Control Panel A (R&D systems, Inc) containing low, medium and
high mixtures of the cytokines and chemokines measured in this
study was used to validate the results.
Statistical analysis
Data were entered into Excel and were analysed using STATA
software version 8 (Stata, Corporation, USA.) and Prism
(GraphPad Inc.). Non-normal data were log transformed and
most remained non-normal (Shapiro-Wilks test). Non-parametric
tests (Spearman’s rank correlation, Kruskal-Wallis with Dunn’s
post test) were used throughout. For Spearman’s rank correlation
the correlation coefficient ‘rs’ is given. Significant correlations
are represented by *(p=0.01–0.05), **(p=0.001–0.01) and
*** (p=,0.001). For between group differences only groups with
a significant Kruskal-Wallis (K–W) p value (p= ,0.05) were
reported. Significant Dunn’s post-test (DPT) p values (p= ,0.05)
for multiple comparisons are given.
Supporting Information
Table S1 Summary of demographic data, clinical characteristics
and laboratory results for patients in the study. * One P. vivax
patient had complicated disease. Pre-treatment values and mea-
surements are summarised as median (inter quartile range) except
where stated differently. Numbers in square brackets, [ ], = n
when different from total number of patients in each groups.
(DOC)
Table S2 Comparison of available data from 304 P. falciparum
patients, St George’s Healthcare Trust (SGHT) and 22 P.
falciparum patients recruited prospectively in Malaysian Borneo.
Median (Interquartile range) is given except for parasitaemia
where geometric mean (interquartile range are given). P values
derived using the Mann-Whitney U test.
(DOC)
Table S3 Classification of patients recruited with severe malaria.
Frequency of WHO markers of severity in malaria patients with
complicated disease (http://rbm.who.int/docs/hbsm.pdf). Several
patients met more than one criterion. * Patient developed anaemia
on day 1.
(DOC)
Table S4 Correlation between parasitaemia and immune
mediators. Spearman’s rank correlation ‘rs’ value is given; *, **
and *** denote the level of significance of the correlation, ‘–’
denotes inverse associations and ns = no significant correlation.
(DOC)
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